In silico design of novel precision vaccine targeting sclerostin epitopes for osteoporosis prevention and treatment
BackgroundOsteoporosis has become an increasingly pressing global public health challenge. Monoclonal antibody romosozumab (ROMO), which targets sclerostin (SOST), a critical inhibitor of bone formation, demonstrates considerable therapeutic efficacy. …